By using a diverse set of transcriptomic SARS-CoV-2 signatures, US researchers put to use their previously developed drug repositioning pipeline to pinpoint potential drug candidates for the treatment of coronavirus disease (COVID-19). The study is currently available on the bioRxiv* preprint server. While many efforts are currently underway to identify potential therapies targeting various aspects